Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Return on Invested Capital: 2024-2025

Historic Return on Invested Capital for Iovance Biotherapeutics (IOVA) over the last 1 years, with Sep 2025 value amounting to -0.59%.

  • Iovance Biotherapeutics' Return on Invested Capital fell 4.00% to -0.59% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.59%, marking a year-over-year decrease of 4.00%. This contributed to the annual value of -0.61% for FY2024, which is N/A change from last year.
  • Iovance Biotherapeutics' Return on Invested Capital amounted to -0.59% in Q3 2025, which was down 10.99% from -0.53% recorded in Q1 2025.
  • In the past 5 years, Iovance Biotherapeutics' Return on Invested Capital registered a high of -0.53% during Q4 2024, and its lowest value of -0.73% during Q1 2024.
  • Over the past 2 years, Iovance Biotherapeutics' median Return on Invested Capital value was -0.57% (recorded in 2024), while the average stood at -0.59%.
  • Over the last 5 years, Iovance Biotherapeutics' Return on Invested Capital had its largest YoY gain of 20bps in 2025, and its largest YoY loss of 4bps in 2025.
  • Over the past 2 years, Iovance Biotherapeutics' Return on Invested Capital (Quarterly) stood at -0.53% in 2024, then fell by 4bps to -0.59% in 2025.
  • Its Return on Invested Capital stands at -0.59% for Q3 2025, versus -0.53% for Q1 2025 and -0.53% for Q4 2024.